Get 250+ investors tailored to your startup

Invest in your industry and stage
Emails & contact info included
Excel and CSV export
Automatically

Trusted by 3,000+ startups

Top 5 Medical VC (Venture Capital) Funds in Hungary in January 2025

Last updated: Jan 2025 A list of 5 VC (Venture Capital) funds that invest in Medical startups based in Hungary. We rank investors based on the number of investments they made in Medical companies from Hungary. We update this investor list every month.

Top 5 Medical VC (Venture Capital) Funds in Hungary in January 2025

Investor	Medical Hungary investments
FastVentures	1
Solus Capital	1
Value4Capital	1
Ananda Impact Ventures	1
Texas HALO Fund	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

venture capital

Show more

Investment focus

Software, Biotechnology, Information Technology
Seed, Series A, Series B
Hungary, South Korea, United States

Portfolio highlights

Iskra — Iskra offers web3 gaming opportunities using blockchain and rewards its stakeholders based on their participation.
On Vacation — On Vacation is a chat-based concierge service where customers may get help making reservations and getting personalized and optimal tours from travel specialists.
NextChapter — NextChapter is a digital commerce platform that acquires and operates Coupang and Naver-based online native brands in Korea. NextChapter is backed by BlueRun Ventures/BRV Capital Management, Goodwater Capital, Klim Ventures, Fast Ventures and Sandbox Network.NextChapter was founded in 2021 by Joshua Kwon and Jay Chung and is headquarteredin Seoul, Korea.

Solus Capital is a seed & early growth VC investment company

Show more

Investment focus

Software, Information Technology, Machine Learning
Seed, Series A, Pre-Seed
Hungary

Portfolio highlights

Quino — AI-driven workspace for students. Summarize and chat with any document. Share your findings with your friends. Learn Easy. Learn Fast.
Duelbox — Customized games for any event. Build an unforgettable event with our ever-growing game universe that's made to be personalized.
YourAnastomosis — Why are we needed?Until recently, there were no objective methods to evaluate the quality of the practice of vessel anastomosis (vascular suture) for cardiac surgeons, vascular surgeons, and surgical trainees. It was not possible to know how one surgically created vessel suture will behave, and what its long-term effectiveness will be.How arewe solving these challenges?Our technological innovations provide objective feedback about the quality of anastomoses during surgical training. Our method can be used as a convenient and gamified system, for surgical education and training for attendees, learners from all stages of training and levels of expertise. What do we offer?Your Anastomosis offers anastomosis (vascular suture) analysis for surgeons, surgical trainees and medical students. Our technology provides simulated environments, by digitizing and blood flow conditions, and evaluating short and long-term results of the specific vessel. The innovation in our technology allows for an objective assessment of an anastomosis, creating clear surgical and technical suggestions for improvement.

Private equitycentral europe

Show more

Investment focus

Medical, Health Care, Medical Device
Private Equity
Hungary

Portfolio highlights

Doctor24 — Doktor24 group of companies are able to serve all emerging individual and corporate customer needs in the following areas: allergology, internal medicine, dermatology, dietetics, otolaryngology, cardiology, gynecology, orthopedics, rheumatology, ophthalmology, urology, blood sampling without queuing, imaging diagnostics ( X-rays, ultrasound,mammography), complex health screenings (so-called managerial screening).

We are the home for entrepreneurs with a big vision who want to create something less ordinary. Something that matters. For all of us.

Show more

Investment focus

Health Care, Software, Information Technology
Seed, Funding Round, Series A
Germany, United Kingdom, Finland

Portfolio highlights

Klim — Klim enables farmers to transition to regenerative agriculture at scale by providing them financial support, knowledge, documentation tools, and a community via our digital companion for farmers.Klim-verified carbon removal credits, generated by Klim farmers, help companies to transition to net zero by offsetting their carbon emissions locallyand with maximum impact and transparency.
OroraTech — OroraTech provides global real-time information services. The first target market is early detection and monitoring of wildfires, extended by a proprietary constellation of thermal imaging nanosatellites equipped with in-space AI image processing. At the beginning of 2020, OroraTech launched an MVP called Wildfire Service (WFS) that enables quickdetection and monitoring of wildfires on a global scale. The combination of existing thermal-infrared satellite data with external data layers, such as fuel, wind, and risk maps results in an automatic generation of fire alerts and the display of current fire perimeters for users. The MVP was launched in early 2020 and has gained increasing traction with governmental and large corporate customers all over the world.
Decade Energy — Decade Energy is the energy infrastructure and optimization partner for transport operators and depot managers who want to electrify their fleets.

Early Stage Venture Investments

Show more

Investment focus

Health Care, Medical Device, Software
Seed, Convertible Note, Series A
United States, Canada, Hungary

Portfolio highlights

Flourish Collective — FlourishFund is a digital platform that empowers and supports new and expecting families. The platform consists of two parts: a marketplace with evidence-based goods and vetted maternal wellness services and a funding mechanism for friends and families to contribute to a positive birth and parenting journey.
Drusolv Therapeutics — Drusolv Therapeutics is a clinical-stage drug company developing a novel, high-dose statin for early intervention in age-related macular degeneration. Their product ocustatin is aimed at patients who are still in the intermediate stage of the disease and currently have very limited options to prevent progression to late-stage vision loss. Ocustatinwas developed at Harvard University and has been validated in a very successful proof-of-concept clinical trial that showed a 75% reduction in progression to late-stage blindness. John Edwards, the founder and CEO of Drusolv, is a serial entrepreneur with extensive experience in AMD.
Vartega — Vartega is a technology development company specializing in the carbon fiber-reinforced plastic recycling process. We have developed alternative technology, processes, and equipment to provide low-cost carbon fiber for use in mass market applications.

Investors by industry

Artificial intelligence

Venture Capital

Food and Beverage

Financial Services

Enterprise Software

Mobile Advertising

Wine And Spirits

Renewable Energy

Agriculture (agtech)

Media (entertainment)

Investors by country

Russian Federation

Dominican Republic

United Arab Emirates

Marshall Islands

VC (Venture Capital) Funds in Hungary by industry

Financial Services

Artificial intelligence

Media (entertainment)

Agriculture (agtech)